Ce document numérisé est le fruit d'un long travail approuvé par le ...

26 C. Huin et al. / Bi%gy ofthe Cel! 94 (2002) 15-27
References
Altiok, S., Xu, M., Spiegelman, B.M., 1997. PPARy induces cell cycle
withdrawal: inihibition of E2FIDP DNA-binding activity via downregnlation
of PP2A Genes Dev. Il, 1987-1998.
Auboeuf, D., Rieusset, l, Fajas, L., Vallier, P., Freing, v., Riou, J.P.,
Laville, M., Staels, B., Auwerx, J., Vidal, H., 1997. Tissue distribution
and quantification of the expression of peroxisome proliferatoractivated
receptors and liver X receptor-alpha in humans: no alteration
in adipose tissue of obese and NIDDM patients. Diabetes 46,
1319-1327.
Aviv, H., Leder, P., 1972. Purification of biologically active protein globin
messenger RNA by chromatography on oligothymidylic acid--œllulose.
Proc. Natl. Acad. Sci. USA 69, 1408-1412.
Baudhuin, S.B., Beaufay, H., Rahman-Li, Y., Sellinger, O.Z., Wattiaux, R,
Jacques, P., de Duve, C., 1964. Tissue fractionation studies. 17 ­
Intracellular distribution of monoaminotransferase, d-aminoacid oxidase
and catalase in rat liver tissue. Biochem. J. 92, 179-184.
Brockman, J.A., Gupta, RA, Dubois, R.N., 1998. Activation of PPARy
leads to inhibition of anchorage-independent growth of human colorectal
cancer cells. Gastroenterology 115, 1049-1055.
Cablé, S., Keller, lM., Colin, S., Haffen, K, Kedinger, M., Parache, R.M.,
Dauça, M., 1992. Peroxisomes in human colon carcinomas. A cytochemical
and biochemical study. Virchows Archiv. B. Cell Pathol. 62,
221-226.
Chawla, A., Schwarz, E.J., Dimaculangan, D.D., Lazar, M.A, 1994.
Peroxisome proliferator-activated receptor (PPAR) gamma: adipose
predominant expression and induction early in adipocyte differentiation.
Endocrinology 135, 798-800.
Chomczynski, P., Sacchi, N., 1987. Single-step method of RNA isolation
by acid guanidium thiocyanate-phenol-chloroform extraction. Anal.
Biochem. 162, 156-159.
Dauça, M., Cablé, S., Calvert, R., Colin, S., Schilt, J., Leheup, B.,
Keller, J.M., Menard, D., 1996. Peroxisomes and peroxisomal enzymes
in the human fetal small intestine. Biol. Neonate 69, 12-21.
Demetri, GD., Fletcher, C.D., Mueller, E., Sarraf, P., Naujoks, R,
Campbell, N., Spiegelman, B.M., Singer, S., 1999. Induction of solid
tumor differentiation by the peroxisome proliferator-activated receptorgamma
ligand troglitazone in patients with liposarcoma. Proc. Natl.
Acad. Sci. USA 96, 3951-3956.
Desvergne, B., Wahli, W., 1995. PPAR: a key nuclear factor in
nutrient/gene interactions? In: Baeuerle, P. (Ed.), Inducible Transcription,
Vol 1. Birkhaüsser, Boston, pp. 142-176.
Duclos, S., Bride, J., Ramirez, L.C., Bournot, P., 1997. Peroxisome
proliferation and beta-oxidation in FaO and MH1C1 rat hepatoma cells,
HepG2 human hepatoblastoma cells and cultured human hepatocytes:
effect of ciprofibrate. Eur. J. Cell Biol. 72, 314-323.
El Bouthoury, E, Keller, J.M., Colin, S., Parache, RM., Dauça, M., 1992.
Peroxisomal enzymes in normal and tumoral human breast. J. Pathol.
166, 27-35.
Elbrecht, A., Che, Y., Cullinan, C.A., Hayes, N., Leibowitz, M.D.,
Moller, D.E., Berger, J., 1996. Molecular cloning, expression and
characterization of human peroxisome proliferator-activated receptors
YI and yz. Biochem. Biophys. Res. Commun. 224, 431-437.
Fajas, L., Auboeuf, D., Raspe, E., Schoonjans, K, Lefebvre, A.M.,
Saladin, R., Najib, J., Fruchart, J.C., Deeb, S., Vidal-Puig, A, Flier, J.,
Briggs, M.R., Staels, B., Vidal, H., Auwerx, J., 1997. The organisation,
promoter analysis, and expression of the human PPARy gene. J. Biol.
Chem. 272, 18779-18789.
Fajas, L., Fruchart, J.c., Auwerx, J., 1998. PPARY3 mRNA: a distinct
PPARy mRNA subtype transcribed from an independent promoter.
FEBS Lett. 438, 55-60.
Farrants, A.K, Nilsson, A., Troen, G., Blomhoff, R., Pedersen, J.L, 1993.
The effect of retinoids and clofibric acid on the peroxisomal oxidation
of palmitic acid and 3 alpha, 7 alpha, 12 alpha-trihydroxy-5 betacholestanoic
acid in rat and rabbit hepatocytes. Biochim. Biophys. Acta
1168, 100-107.
Fogh, J., Trempe, G., 1975. New human tumor celllines. In: Fogh, J. (Ed.;
Human Tumor Cells In Vitro. Plenum Press, New York, pp. 115-141
Garen, A, Levinthal, C., 1960. A fine structure genetic and chemical stud:
of the enzyme alkaline phosphatase of E. coli. Purification and charac
terization of alkaline phosphatase. Biochim. Biophys. Acta 38
470-483.
Gebel, T., Arand, M., Oesch, P., 1992. Induction of the peroxisollli
proliferator-activated receptor by fenofibrate in rat liver. FEBS Lett
309,37-40.
Gonzalez, EJ., 1997. Recent update on the PPARa-null mouse. Biochimi,
79, 139-144.
Hryb, DJ., Hogg, J.E, 1979. Chain length specificities of peroxisomal aU(
mitochondrial beta-oxidation in rat liver. Biochem. Biophys. Res
Commun. 87, 1200-1206.
Huin, C., Corriveau, L., Bianchi, A., Keller, J.M., Collet, P., Krémarik
Bouillaud, P., Domenjoud, L., Bécuwe, P., Schohn, H., Ménard, D.
Dauça, M., 2000. Differentiai expression of peroxisome proliferator·
activated receptors (PPARs) in the developing human fetal digestiv<
tract. J. Histochem. Cytochem. 48, 1-9.
Kitamura, S., Miyazaki, Y., Shinomura, Y., Kondo, S., Kanayama, S"
Matsuzawa, Y., 1998. Peroxisome proliferator-activated receptor 't
induces growth arrest and differentiation markers of human colon
cancer cells. Jpn. Cancer Res. 90, 75-80.
Kubota, T., Koshizuka, K, Williamson, E.A, Asou, H., Said, J.w.,
Holden, S., Miyoshi, L, Koeffer, H.P., 1998. Ligand for peroxisome
proliferator-activated receptor gamma., troglitazone has potent antitumor
effects against human prostate cancer both in vitro and in vivo.
Cancer Res. 58, 3344-3352.
Lauer, c., Valkl, A., Riedl, S., Fahimi, H.D., Beier, K, 1999. Impairment
of peroxisomal biogenesis in human colon carcinoma. Cancer Biol. 20,
985-989.
Lefebvre, A.M., Chen, L, Desreumeaux, P., Najib, J., Fruchart, J.c.,
Geboes, K, Heyman, R, Auwerx, J., 1998. Activation of the peroxisome
proliferator-activated receptor Y enhances the development of
colon cancer tumors in C57BL/6J, _APcmin/+mice. Nat. Med. 4,
1053-1057.
Lee, S.S., Pineau, T., Drago, J., Lee, EJ., Owens, J.W., Kroetz, D.L.,
Fernandez-Salguero, P.M., Westphal, H., Gonzalez, FJ., 1995. Targeted
disruption of the alpha isoform of the peroxisome proliferator-activated
receptor gene in mice results in abolishment of the pleiotropic effects of
peroxisome proliferators. Mol. Cell Biol. 15, 3012-3022.
Lemberger, T., Desvergne, B., Wahli, w., 1996. Peroxisome proliferatoractivated
receptors: a nuclear receptor signaling pathway in lipid
physiology. Annu. Rev. Cell. Dev. Biol. 12, 335-363.
Lowry, O.H., Rosebrough, N.J., Farr, AL., Randall, RJ., 1951. Protein
measurement with the Folin phenol reagent. J. Biol. Chem. 193,
265-275.
Mansen, A., Guardioladiaz, H., Rafter, J., Branting, c., Gustafsson, J.A.,
1996. Expression of the proliferator activated receptor (PPAR) in the
mouse colonic mucosa. Biochem. Biophys. Res. Commun. 222,
844-851.
Marx, N., Sukhova, G., Murphy, c., Libby, P., Plutzky, J., 1998. Macrophages
in human atheroma contain PPARy: differentiation-dependent
peroxisomal proliferator-activated receptor gamma., PPARy expression
and reduction of MMP-9 activity through PPARy in mononuclear
phagocytes in vitro. Am. J. Pathol. 153, 17-23.
Messer, M., Dahlqvist, A, 1966. A one-step ultramicromethod for the assay
of intestinal disaccharidases. Anal. Biochem. 14, 376-392.
Mueller, E., Sarraf, P., Tontonoz, P., Evans, RM., Martin, KJ., Zhang, M.,
Fletcher, C., Singer, S., Spiegelman, B.M., 1998. Terminal differentiation
of human breast cancer through PPARy. Mol. Cell. 1,465-470.
Mukherjee, R, Jow, L., Noonan, D., McDonnell, D.P., 1994. Human and
rat peroxisome proliferator-activated receptors (PPARs) demonstrate
similar tissue distribution but different responsiveness to PPAR activators.
J. Steroid Biochem. Mol. Biol. 51, 157-166.